Inflammatory Heart Disease Market
Global Inflammatory Heart Disease Market Size, Share & Trends Analysis Report by Type (Atherosclerosis, Myocarditis, and Pericarditis), by Treatment (Medicine, Antibiotics, Anti-Inflammatory Medications, Surgeries, and Others), and by Diagnostic Test (Electrocardiogram, Echocardiogram, X-Ray, Myocardial Biopsy, and Chest MRI) Forecast Period (2022-2028)
The global inflammatory heart disease market is anticipated to grow at a substantial CAGR during the forecast period. Inflammatory heart disease is mainly caused by various infectious agents which include viruses, bacteria, fungi, and parasites. These infectious agents came into contact with the human body via various toxic materials from the environment, water, food, air, toxic gases, smoke, and pollution. Its major symptoms include chest pain, pain in heart muscle, shortness of breath, swelling of feet or ankles, and fatigue. Changing lifestyles results in a higher prevalence of viral and fungal infections which is one of the major factors motivating the growth of this market.
Impact of COVID-19 Pandemic on Global Inflammatory Heart Disease Market
During COVID-19 the production and demand for medical treatment and equipments has been increased which led to the inflammatory heart disease market growth globally.
Segmental Outlook
The global inflammatory heart disease market is segmented based on Type, Treatment, and diagnostic tests. Based on Type, the market is further diversified into atherosclerosis, myocarditis, and pericarditis. Based on the Treatment, the market is bifurcated into medicine, antibiotics, anti-inflammatory medications, surgeries, and others. Based on the diagnostic test, the market is bifurcated into the electrocardiogram, echocardiogram, x-ray, myocardial biopsy, and chest MRI.
Global Inflammatory Heart Disease Market Share by Diagnostic Tests, 2021 (%)
The Electrocardiogram Diagnostic Test is Expected to Hold Considerable Share in the Global Inflammatory Heart Disease Market
An Electrocardiogram (ECG) is a quick and painless test that records the electrical signals in heart. It can spot abnormal heart rhythms. People may have an ECG while they’re at rest or while exercising (stress electrocardiogram). ECG is most common and quick test mostly recommended by the doctors. In May 2022, AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, launched KardiaComplete, a comprehensive heart health enterprise solution designed to drive improved health outcomes and reduce the cost of cardiac care. The service will be available to people diagnosed with hypertension and arrhythmias, like atrial fibrillation, through their self-insured employers, health insurance plans and health systems.
Regional Outlooks
The global Inflammatory heart disease market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North America is expected to hold a prominent market share in the inflammatory heart disease market during the forecast. The Asia-Pacific region and Europe region is considered the fastest-growing region in the market.
Global Inflammatory Heart Disease Market Growth, by Region 2022-2028
The North American Region is Expected to Hold a Considerable Share in the Global Inflammatory Heart Disease Market
The North American region represents considerably the largest market for inflammatory heart disease due to the high prevalence and treatment cost of cardiovascular disease. According to the US Department of Health & Human Services, about 659,000 people in the United States die from heart disease each year. The increase in smoking and alcohol consumption has shown an adverse effect and increases the number of inflammatory heart disease patients. According to the 2019 National Survey on Drug Use and Health (NSDUH), 25.8% of people ages 18 and older (29.7% of men in this age group and 22.2% of women in this age group) reported that they engaged in binge drinking in the past month, and 6.3% (8.3% of men in this age group and 4.5% of women in this age group) reported that they engaged in heavy alcohol use in the past month.
Market Players Outlook
The major companies serving the global inflammatory heart disease market include Abbott Laboratories, Bayer AG, Merck & co. Inc., Johnson & Johnson, Teva Pharmaceutical Industries, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new diagnostic test launches, to stay competitive in the market. For instance, in January 2021, The US Food and Drug Administration (FDA) approved Merck and Bayer’s heart failure drug vericiguat, an orally administered soluble guanylate cyclase (sGC) stimulator.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global inflammatory heart disease market. Based on the availability of data, information related to new diagnostic test launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Inflammatory Heart Disease Market
• Recovery Scenario of Global Inflammatory Heart Disease Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Abbott Laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Bayer AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Merck & co. Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Johnson & Johnson
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Teva Pharmaceutical Industries
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
3.8. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Inflammatory Heart Disease Market by Type
4.1.1. Atherosclerosis
4.1.2. Myocarditis
4.1.3. Pericarditis
4.2. Global Inflammatory Heart Disease Market by Treatment
4.2.1. Medicine
4.2.2. Antibiotics
4.2.3. Anti-Inflammatory Medications
4.2.4. Surgeries
4.2.5. Others
4.3. Global Inflammatory Heart Disease Market by Diagnostic Test
4.3.1. Electrocardiogram
4.3.2. Echocardiogram
4.3.3. X-Ray
4.3.4. Myocardial Biopsy
4.3.5. Chest MRI
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profile
6.1. Amgen
6.2. Astellas Pharma, Inc.
6.3. Astrazeneca
6.4. Boehringer Ingelheim Gmbh
6.5. Bristol-Myers Squibb Co.
6.6. Eli Lilly And Co.
6.7. Hoffmann-La Roche Ltd.
6.8. Gilead Sciences, Inc.
6.9. Mayo Clinic
6.10. Novartis AG
6.11. Otsuka Holdings Co. Ltd.
6.12. Pfizer Inc.
6.13. Sanofi
6.14. Takeda Pharmaceuticals Company Ltd.
1. GLOBAL INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ATHEROSCLEROSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL MYOCARDITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL PERICARDITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL INFLAMMATORY HEART DISEASEMARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
6. GLOBAL INFLAMMATORY HEART DISEASE MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL INFLAMMATORY HEART DISEASE ANTIBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL INFLAMMATORY HEART DISEASE ANTI-INFLAMMATORY MEDICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL INFLAMMATORY HEART DISEASE SURGERIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL OTHER INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL INFLAMMATORY HEART DISEASEMARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TEST, 2021-2028 ($ MILLION)
12. GLOBAL ELECTROCARDIOGRAM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL ECHOCARDIOGRAM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL X-RAY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL MYOCARDIAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL CHEST MRI MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL INFLAMMATORY HEART DISEASEMARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
18. NORTH AMERICAN INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. NORTH AMERICAN INFLAMMATORY HEART DISEASEMARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
21. NORTH AMERICAN INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TEST, 2021-2028 ($ MILLION)
22. EUROPEAN INFLAMMATORY HEART DISEASEMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. EUROPEAN INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
24. EUROPEAN INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
25. EUROPEAN INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TEST, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
29. ASIA-PACIFIC INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TEST, 2021-2028 ($ MILLION)
30. REST OF THE WORLD INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
31. REST OF THE WORLD INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
32. REST OF THE WORLD INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
33. REST OF THE WORLD INFLAMMATORY HEART DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TEST, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL INFLAMMATORY HEART DISEASE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL INFLAMMATORY HEART DISEASE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL INFLAMMATORY HEART DISEASE MARKET, 2022-2028 (%)
4. GLOBAL INFLAMMATORY HEART DISEASE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL ATHEROSCLEROSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL MYOCARDITIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL PERICARDITIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL INFLAMMATORY HEART DISEASE MARKET SHARE BY TREATMENT, 2021 VS 2028 (%)
9. GLOBAL INFLAMMATORY HEART DISEASE MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL INFLAMMATORY HEART DISEASE ANTIBIOTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL INFLAMMATORY HEART DISEASE ANTI-INFLAMMATORY MEDICATIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL INFLAMMATORY HEART DISEASE SURGERIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL OTHER TREATMENT INFLAMMATORY HEART DISEASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL INFLAMMATORY HEART DISEASEMARKET SHARE BY DIAGNOSTIC TEST, 2021 VS 2028 (%)
15. GLOBAL ELECTROCARDIOGRAM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL ECHOCARDIOGRAM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL X-RAY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL MYOCARDIAL BIOPSY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL CHEST MRI MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. GLOBAL INFLAMMATORY HEART DISEASEMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21. US INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
22. CANADA INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
23. UK INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
24. FRANCE INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
25. GERMANY INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
26. ITALY INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
27. SPAIN INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF EUROPE INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
29. INDIA INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
30. CHINA INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
31. JAPAN INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
32. SOUTH KOREA INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
33. REST OF ASIA-PACIFIC INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
34. REST OF THE WORLD INFLAMMATORY HEART DISEASE MARKET SIZE, 2021-2028 ($ MILLION)
